What Is Your Valuation? How to Answer Investors in a Pitch

When an investor asks "what is your valuation?", most early-stage founders are better off answering with the round, not a price: how much you are raising, what it buys and roughly how much of the company you expect to sell. In a priced round, many investors suggest letting the lead set the number. In a SAFE round with many small checks, you usually name a cap, ideally one you can defend with market data.

Definition: The valuation question is an investor's request, usually early in a pitch process, for the price at which you plan to sell shares (a pre-money or post-money valuation in a priced round) or the valuation cap on a SAFE or convertible note.

The question sounds like a request for a number. It's usually a test of judgment.

For the mechanics behind the number, see our explainers on pre-money valuation and post-money valuation. For why a high seed price can come back to bite you, see seed valuations and venture return math.

Why investors ask the valuation question

Investors rarely ask because they need your number to make a decision. They ask for three other reasons.

To check fit. A fund that writes $500K checks at $8M caps will not get far with a founder expecting $40M. Asking early saves both sides a month.

To read your judgment. A founder who names a price far outside the market, with no reason behind it, tells the investor something about how they will make other decisions. A founder who can place the round within a market band, and explain why, sounds like someone who has done the homework.

To anchor. Whoever names the first number shapes the rest of the conversation, which is why the answer deserves a plan. Mark Suster of Upfront Ventures builds his 2018 post on the topic around this: the first number frames the deal, and the investor, who sees far more deals than you, has the better information.

Three ways to answer "what is your valuation?"

There is no single correct response. In our view, there are three reasonable approaches, and the right one depends on your instrument, your round structure and how much demand you have.

1. Let the market set the price

You describe the round (amount, milestones, instrument) and say you will let the lead investor propose terms. This is the classic advice for priced rounds. Steve McDermid of a16z, in a 2015 post answering common fundraising questions, cautions founders against opening with a number: an investor who turns down your price is unlikely to change their mind when you come back cheaper. Geoff Ralston's 2016 YC seed guide lands in the same place, suggesting founders leave pricing to the market and to whichever investor leads.

Works best when: you expect a lead, you have more than one investor interested, or you are raising a priced seed or Series A.

2. Anchor with a range or with the raise itself

You give enough to judge fit without naming a figure, for example by stating the amount and expected dilution: "We're raising $2M and expect to sell somewhere in the range seed rounds usually do." Suster's suggested script follows this pattern: signal that you know how rounds are priced and expect to be in the normal range, and that you are optimizing for the right partner rather than the highest price.

Works best when: you are early in the process, interest is building and you want to stay in the conversation without boxing yourself in.

3. Name a cap

In a SAFE round assembled from many angels and small funds, there is often no lead, so someone has to write a number on the document. Usually that's you. Suster himself carves out this exception: when you are raising from many investors rather than one or two, he writes, naming a price can be easier and a price target can help build momentum.

Works best when: you are raising a post-money SAFE from many investors, you have a clear market reference and you can explain how you got there.

Pre-seed and seed valuation data you can anchor on

Whatever approach you choose, know the market before the meeting. Some current reference points, all drawn from companies on Carta's platform:

Use these to locate a band, not to justify one figure. They are medians from one platform, and AI companies often price well above them. Carta's own Q1 2026 State of Private Markets report put a median Series A for an AI foundational model company at around $300M against about $55M for a non-AI startup at the same stage. The spread is also wide. Carta's Peter Walker made exactly that case in April 2026: for a $1M pre-seed raise there is no single correct cap, and how legible a founder's background is to investors can move the price, not just early traction.

How to set a valuation cap before anyone asks

If you plan to name a cap, work it out before the first meeting. Here's one way to do it in five steps.

1. Start from the raise. Size the round to a milestone first (our sibling guide on how much money to raise covers that method).
2. Pick a dilution band. YC's 2016 seed guide suggests most seed rounds sell up to 20 percent and that founders try to stay under 25. Carta's July 2026 benchmarks put median seed dilution at 18 percent. Many founders aim for something in the 10 to 20 percent zone.
3. Back into the post-money. On a post-money SAFE, ownership sold equals the amount raised divided by the cap. So the cap equals the raise divided by the dilution you are willing to accept.
4. Check it against the market. Compare your number with the Carta medians for your round size and sector. If you are far above, ask what makes you different and whether an investor would agree.
5. Stress-test the next round. Ask whether the business can credibly grow into a meaningfully higher price by the next raise. If not, the cap may set you up for a flat or down round.

YC's documents page explains why the post-money SAFE (introduced in 2018) makes step 3 straightforward: founders and investors can calculate immediately how much ownership has been sold. Stacked SAFEs at different caps add up, though, so model them together. Our guide to how SAFEs impact dilution walks through the stacking math.

A worked example: answering with a range

The figures here are illustrative.

A B2B software founder is raising $2M on a post-money SAFE. She wants to sell between 12 and 18 percent of the company.

• At 18 percent dilution, the cap is $2M / 0.18 = about $11.1M.
• At 12 percent, the cap is $2M / 0.12 = about $16.7M.

So her defensible band is roughly $11M to $17M. Carta's February 2026 data puts the median cap for $1M to $2.4M rounds at $15M, inside her band. She picks $15M, which sells $2M / $15M = about 13.3 percent.

Here is how the cap changes what she gives up on the same $2M:

Now the valuation question comes up in a first meeting with a fund that might lead. She could answer with the raise: "We're raising $2M on a post-money SAFE, which funds 20 months and gets us to $1.5M in ARR. We expect to sell somewhere in the low to mid teens." That signals a band of about $13M to $17M without stating one.

If she is filling the round with ten angels and no lead, she names the cap: "$15M post-money cap. That's close to Carta's recent median for rounds our size, and here's the traction behind it."

Same company. Two answers. The difference is who sets the price.

Scripts for the valuation question

These are starting points. Say them in your own words.

Early meeting, priced round likely:

We're raising $3M to reach [milestone] in about 18 months. We know roughly how rounds at our stage price, and we're focused on finding the right lead. We'd expect them to propose terms.

SAFE round, no lead:

We're raising $1.5M on a post-money SAFE with a $12M cap. A few investors have committed, and we picked the cap based on recent market data for rounds our size.

The investor pushes for a number:

We'd rather not anchor before you've had a chance to look at the business. How do you usually think about valuation for companies at our stage?

The investor says your number is high:

That's helpful. What would you need to see to get comfortable there, and where would you expect to land?

Turning the question back is often the most useful move: it tells you whether you are in the same range and moves the anchor to their side. For the rest of that first hour, see our sibling guide on questions VCs ask in a pitch meeting.

Where investors disagree on naming a number

The "never go first" camp. Suster's 2018 post and McDermid's 2015 a16z piece both lean toward letting the investor price the round, on the logic that the side with less information should not anchor.

The "founders set the terms" camp. Paul Graham's 2010 essay "High Resolution Fundraising" describes founders setting caps on convertible notes themselves and even offering different caps to different investors as a round fills, with early believers getting a lower price. That is now normal in SAFE rounds, where the founder fills in the cap.

The "price matters less than you think" camp. Graham's 2013 essay "How to Raise Money" puts valuation third, behind getting the money and getting good investors. Ralston's 2016 YC guide treats the seed price as a minor factor in whether a company ends up working.

Our read: these views fit together once you split by instrument. Priced rounds with a lead favor letting the lead go first. SAFE rounds without a lead need the founder to name a cap. In both cases, a reasonable price you can grow into tends to beat the highest one available. It's our answer, not the answer.

"But a higher valuation means less dilution"

It does, today, and that's a fair argument: ownership you keep at seed compounds through every later round.

But a price also sets a bar. a16z's Jamie McGurk and Steve McDermid made the case in 2014 that an early price set too high becomes a hurdle that can block the next raise at exactly the wrong moment. Elizabeth Yin of Hustle Fund and Renata Quintini of Renegade Partners both made versions of the same point to TechCrunch in 2024, with Quintini noting that an inflated price can hurt the employees who joined early.

Carta's Q1 2026 report put the down-round rate on its platform at 11.4 percent. A down round resets your price, dilutes employees and can trigger anti-dilution protections (our down round guide covers the fallout).

In our view, the extra few points of ownership from a stretched price are rarely worth a meaningful jump in that risk.

Common mistakes with the valuation question

• Quoting a peer's round. A friend's AI company at $40M is not your comparable unless your traction matches.
• Ignoring stacked SAFEs. Three SAFEs at three caps add up to more dilution than any one of them suggests.
• Treating the 409A as your price. A 409A valuation prices common stock for option grants. It is a different number for a different purpose.
• Haggling in the meeting. Ralston's advice is to negotiate away from the pitch, with an adviser. "Let me think about that and come back to you" is a fine answer.

If you want structured practice on the price conversation, the 1752vc Fundraising module inside 1752 Fundraising includes video lessons and guides on how to raise from the 1752vc team, valuation and SAFE terms among them. A membership covers the fundraising tools and is separate from 1752vc's programs. On the program side, 1752vc's Accelerate invests $100K at a valuation cap of up to $3.5M in early-stage startups ready to grow, alongside founder-led sales training and access to a network of 850+ investors.

Where we land

Know the market. Pick a band. Decide in advance who sets the price.

In a priced round, we'd usually let the lead go first and answer with the raise and the milestone. In a SAFE round, we'd name a cap we can explain with data and traction, and plan to grow into it. Either way, the goal is a price that keeps the next round easy, not the biggest number you can get past one investor.

The bottom line

The valuation question isn't really about the number. It's about whether you understand your own round.

Answer with the plan.

Let the price follow.

Key takeaways

• Investors usually ask about valuation to check fit, test your judgment and anchor the negotiation, not because they need your number.
• In priced rounds, many investors suggest letting the lead set the price; in SAFE rounds without a lead, founders typically name the cap.
• Carta data published in February 2026 put the median post-money SAFE cap for $1M to $2.4M rounds at $15M, but caps for the same round size vary widely.
• On a post-money SAFE, the cap equals the raise divided by the dilution you accept, which makes a range easy to calculate before the meeting.
• A price you can grow into tends to protect the next round better than the highest available number, and Carta reported an 11.4 percent down-round rate in Q1 2026.

Frequently asked questions

Should you tell investors your valuation in a pitch meeting?

It depends on the round. In a priced round with a likely lead, many investors suggest describing the raise and milestones and letting the lead propose a price. In a SAFE round from many angels, founders usually state the cap because no one else will. In either case, it helps to know the market range before the meeting so your answer sounds informed.

How do you set a valuation cap on a SAFE?

One common approach is to decide how much you are raising and what share of the company you are willing to sell, then divide the raise by that share. On a post-money SAFE, $2M at 13.3 percent implies a $15M cap. Compare the result with recent market data for your round size and sector, and with what your traction can justify.

What do you say when an investor thinks your valuation is too high?

Ask what they would need to see to get comfortable at your number, and where they would expect a company like yours to price. Their answer tells you whether the gap is small enough to close. You do not need to respond with a counteroffer on the spot; many founders take the feedback away and decide after talking to other investors.

Is a SAFE valuation cap the same as a company valuation?

No. A cap is the maximum valuation at which a SAFE converts into equity in a later priced round, so it limits the investor's price rather than setting the company's value. In practice, many investors and founders still read a post-money cap as a rough proxy for valuation, which is why caps tend to track market pricing.

Can you raise the valuation cap during a round?

Yes, in a SAFE round you can, because each SAFE is a separate agreement. Founders sometimes offer earlier investors a lower cap and raise it for later ones as demand grows, an approach Paul Graham described in 2010. It is worth tracking every cap carefully, since the combined dilution from several SAFEs is what matters at conversion.

Sources

• Y Combinator: A Guide to Seed Fundraising (Geoff Ralston, 2016)
• Y Combinator: Documents (Post-Money SAFE)
• Paul Graham: How to Raise Money (2013)
• Paul Graham: High Resolution Fundraising (2010)
• Both Sides of the Table: How to Talk About Valuation When a VC Asks (Mark Suster, 2018)
• a16z: Raising Capital: This Is the Advice We Give Our Founders (2014)
• a16z: 16 Common Questions About Fundraising (2015)
• TechCrunch: No, Startups Shouldn't Always Take the Highest Valuation, Seed VCs Say (2024)
• Carta: The Latest SAFE Val Cap Trends (Feb 2026)
• Carta: There Is No Correct Valuation Cap for Early Fundraising (Apr 2026)
• Carta: VC Startup Fundraising Benchmarks From 1,000 Rounds (July 2026)
• Carta: State of Private Markets, Q1 2026